Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Madrigal Pharmaceuticals, Inc. (MDGL) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$287.27M
Net Income	$-114.19M
Cost of Goods Sold	$18.12M
Gross Profit	$269.15M
Operating Expenses	$401.24M
Operating Income	$-113.97M
Non-Operating Income/Expense	$-0.21M
Pre-Tax Income	$-114.19M
Normalized Pre-Tax Income	$-114.19M
Income after Taxes	$-114.19M
Income from Continuous Operations	$-114.19M
Consolidated Net Income/Loss	$-114.19M
Normalized Income after Taxes	$-114.19M
EBIT	$-113.97M
EBITDA	$-111.74M
Weighted-Average Shares Outstanding (Basic)	22.48M
Weighted-Average Shares Outstanding (Diluted)	22.48M
Earnings per Share (EPS) (Basic)	$-5.08
Earnings per Share (EPS) (Diluted)	$-5.08
Balance Sheet Financials
Current Assets	$1.35B
Property, Plant, and Equipment	$2.91M
Long-Term Assets	$15.78M
Total Assets	$1.36B
Current Liabilities	$391.41M
Long-Term Debt	$339.75M
Long-Term Liabilities	$345.32M
Total Liabilities	$736.73M
Common Equity	$625.73M
Tangible Shareholders Equity	$618.26M
Shareholders Equity	$625.73M
Common Shares Outstanding	22.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-56.09M
Cash Flow from Investing Activities	$4.74M
Cash Flow from Financial Activities	$247.03M
Beginning Cash	$105.02M
End Cash	$300.69M
Increase/Decrease in Cash	$195.68M
Stock-Based Compensation	$72.34M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.54
Gross Margin	93.69%
Operating Margin	-39.68%
EBIT Margin	-39.68%
EBITDA Margin	--
Pre-Tax Profit Margin	-39.75%
Profit Margin	-39.75%
Free Cash Flow	$-56.95M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.26
Receiveable Turnover	2.54
Days Sales in Receivables	35.49
Return on Equity	-18.25%
Return on Tangible Equity	-18.47%
Return on Assets	-8.38%
Return on Investments	-11.83%
Book Value Per Share	$27.56
Free Cash Flow per Share	$-2.53
Operating Cash Flow per Share	$-2.49

Data from Zacks Investment Research, Inc.